Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion

Detalles Bibliográficos
Autores principales: Kurozumi, Kazuhiko, Fujii, Kentaro, Washio, Kana, Ishida, Joji, Otani, Yoshihiro, Sudo, Tamotsu, Tahara, Makoto, Ichimura, Koichi, Ennishi, Daisuke, Date, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268733/
https://www.ncbi.nlm.nih.gov/pubmed/35821677
http://dx.doi.org/10.1093/noajnl/vdac094
_version_ 1784744057641107456
author Kurozumi, Kazuhiko
Fujii, Kentaro
Washio, Kana
Ishida, Joji
Otani, Yoshihiro
Sudo, Tamotsu
Tahara, Makoto
Ichimura, Koichi
Ennishi, Daisuke
Date, Isao
author_facet Kurozumi, Kazuhiko
Fujii, Kentaro
Washio, Kana
Ishida, Joji
Otani, Yoshihiro
Sudo, Tamotsu
Tahara, Makoto
Ichimura, Koichi
Ennishi, Daisuke
Date, Isao
author_sort Kurozumi, Kazuhiko
collection PubMed
description
format Online
Article
Text
id pubmed-9268733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92687332022-07-11 Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion Kurozumi, Kazuhiko Fujii, Kentaro Washio, Kana Ishida, Joji Otani, Yoshihiro Sudo, Tamotsu Tahara, Makoto Ichimura, Koichi Ennishi, Daisuke Date, Isao Neurooncol Adv Brief Communication Oxford University Press 2022-06-13 /pmc/articles/PMC9268733/ /pubmed/35821677 http://dx.doi.org/10.1093/noajnl/vdac094 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Communication
Kurozumi, Kazuhiko
Fujii, Kentaro
Washio, Kana
Ishida, Joji
Otani, Yoshihiro
Sudo, Tamotsu
Tahara, Makoto
Ichimura, Koichi
Ennishi, Daisuke
Date, Isao
Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
title Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
title_full Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
title_fullStr Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
title_full_unstemmed Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
title_short Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
title_sort response to entrectinib in a malignant glioneuronal tumor with arhgef2-ntrk fusion
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268733/
https://www.ncbi.nlm.nih.gov/pubmed/35821677
http://dx.doi.org/10.1093/noajnl/vdac094
work_keys_str_mv AT kurozumikazuhiko responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT fujiikentaro responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT washiokana responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT ishidajoji responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT otaniyoshihiro responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT sudotamotsu responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT taharamakoto responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT ichimurakoichi responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT ennishidaisuke responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion
AT dateisao responsetoentrectinibinamalignantglioneuronaltumorwitharhgef2ntrkfusion

Ejemplares similares